Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis

Abstract CD146, also known as melanoma cell adhesion molecule, was initially identified as a marker of melanoma progression and metastasis. Recently many clinical studies investigated overexpression of CD146 predict poor prognosis of solid tumor, however, the results was inconclusive, partly due to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ping Zeng, Hai Li, Pei-Hua Lu, Li-Na Zhou, Min Tang, Chao-Ying Liu, Min-Bin Chen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3d9180d5f20a43069f422a82c37728da
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3d9180d5f20a43069f422a82c37728da
record_format dspace
spelling oai:doaj.org-article:3d9180d5f20a43069f422a82c37728da2021-12-02T11:41:00ZPrognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis10.1038/s41598-017-01061-32045-2322https://doaj.org/article/3d9180d5f20a43069f422a82c37728da2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01061-3https://doaj.org/toc/2045-2322Abstract CD146, also known as melanoma cell adhesion molecule, was initially identified as a marker of melanoma progression and metastasis. Recently many clinical studies investigated overexpression of CD146 predict poor prognosis of solid tumor, however, the results was inconclusive, partly due to small numbers of patients included. This present meta-analysis was therefore performed utilizing the results of all clinical studies concerned to determine the prognostic value of CD146 expression in solid tumors. Relevant articles were identified through searching the PubMed, Web of Science and Embase database. In this meta-analysis, 12 studies involving 2,694 participants were included, and we drew the conclusion that strong significant associations between CD146 expression and all endpoints: overall survival (OS) [hazard ratio (HR) = 2.496, 95% confidence interval (95% CI) 2.115–2.946], time to progression (TTP) (HR = 2.445, 95% CI 1.975–3.027). Furthermore, the subgroup analysis revealed that the associations between CD146 overexpression and the outcome endpoints (OS or TTP) were significant in Mongoloid patients and Caucasian patients, as well in patients with lung cancer and digestive system cancer. In conclusion, these results showed that high CD146 was associated with poor survival in human solid tumors. CD146 may be a valuable prognosis predictive biomarker; nevertheless, whether CD146 could be a potential therapeutic target in human solid tumors needs to be further studied.Ping ZengHai LiPei-Hua LuLi-Na ZhouMin TangChao-Ying LiuMin-Bin ChenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ping Zeng
Hai Li
Pei-Hua Lu
Li-Na Zhou
Min Tang
Chao-Ying Liu
Min-Bin Chen
Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
description Abstract CD146, also known as melanoma cell adhesion molecule, was initially identified as a marker of melanoma progression and metastasis. Recently many clinical studies investigated overexpression of CD146 predict poor prognosis of solid tumor, however, the results was inconclusive, partly due to small numbers of patients included. This present meta-analysis was therefore performed utilizing the results of all clinical studies concerned to determine the prognostic value of CD146 expression in solid tumors. Relevant articles were identified through searching the PubMed, Web of Science and Embase database. In this meta-analysis, 12 studies involving 2,694 participants were included, and we drew the conclusion that strong significant associations between CD146 expression and all endpoints: overall survival (OS) [hazard ratio (HR) = 2.496, 95% confidence interval (95% CI) 2.115–2.946], time to progression (TTP) (HR = 2.445, 95% CI 1.975–3.027). Furthermore, the subgroup analysis revealed that the associations between CD146 overexpression and the outcome endpoints (OS or TTP) were significant in Mongoloid patients and Caucasian patients, as well in patients with lung cancer and digestive system cancer. In conclusion, these results showed that high CD146 was associated with poor survival in human solid tumors. CD146 may be a valuable prognosis predictive biomarker; nevertheless, whether CD146 could be a potential therapeutic target in human solid tumors needs to be further studied.
format article
author Ping Zeng
Hai Li
Pei-Hua Lu
Li-Na Zhou
Min Tang
Chao-Ying Liu
Min-Bin Chen
author_facet Ping Zeng
Hai Li
Pei-Hua Lu
Li-Na Zhou
Min Tang
Chao-Ying Liu
Min-Bin Chen
author_sort Ping Zeng
title Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
title_short Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
title_full Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
title_fullStr Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
title_full_unstemmed Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis
title_sort prognostic value of cd146 in solid tumor: a systematic review and meta-analysis
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/3d9180d5f20a43069f422a82c37728da
work_keys_str_mv AT pingzeng prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis
AT haili prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis
AT peihualu prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis
AT linazhou prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis
AT mintang prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis
AT chaoyingliu prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis
AT minbinchen prognosticvalueofcd146insolidtumorasystematicreviewandmetaanalysis
_version_ 1718395456370769920